The effect of a nebulized bronchodilator administered with or without intermittent positive pressure breathing on ventilatory function in children with cystic fibrosis and asthma.
D000328:Adult; D000336:Aerosols; D000402:Airway Obstruction / Q000188:drug therapy; D000403:Airway Resistance / Q000187:drug effects; D001249:Asthma / Q000188:drug therapy*; D002648:Child; D003550:Cystic Fibrosis / Q000188:drug therapy*; D006801:Humans; D007545:Isoproterenol / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D011175:Positive-Pressure Respiration; D012129:Respiratory Function Tests; D013147:Spirometry; D014797:Vital Capacity
D000336:Aerosols; D007545:Isoproterenol